Program Overview

Program Overview

Day 1 Liver cancer (Hepatocellular carcinoma)

Day 2 Pancreatic cancer, and other liver cancer

Day 3 Thyroid, and all other cancers

Lectures, Panel discussions, Case presentations

Liver cancer

Hepatocellular carcinoma
  • Staging and management stratification: Is HKLC better than BCLC?
  • Imaging diagnosis of HCC – The role of primovist
  • Post-treatment imaging follow up
  • Anti-viral therapy for patients with HBV
  • Immunotherapy for HCC
  • Systemic therapy for HCC
  • The role of local ablation as a curative treatment for early HCC
  • Combined transarterial treatment and local ablation for massive HCC in contact with blood vessels
  • Combined targeted therapy and transarterial treatment for advanced HCC with extrahepatic disease or venous tumor
  • Treatment for patients with portal vein tumor thrombus
  • Downstaging of HCC
Options of local ablation
  • Radiofrequency ablation (RFA) - Is it out dated or not?
  • Microwave ablation – Is it more powerful for larger tumors?
Panel discussion and case presentations on options of local ablation: How to choose what treatment options to use?
Techniques of local ablation
  • Percutaneous RFA of HCC: Technical Tips and Tricks for Tumor Location
  • Percutaneous RFA of HCC: Emerging techniques
  • Precision ablation of large tumors using 3-Dimensional visualization platform
Options of transarterial treatment:
  • Lipiodol-based TACE – Why are we still doing it?
  • DEB TACE - Is this just another TACE
  • Hepasphere TACE - Is this just another TACE
  • Bead Block TACE – Is this just another TACE
  • • Radioembolization – What is the magic about this?
Panel discussion and case presentations on options of transarterial treatment : How to choose what treatment options to use?
Emerging options of treatment:
  • Transarterial ethanol ablation/ Ablative chemoembolization
  • DSM-TACE
  • Intra-tumoral immunotherapy
Techniques of transarterial treatment:
  • Angio-architecture and hemodynamic in HCC, including angiographic classification in HCC, intra and extrahepatic supplies, portal venous hemodynamic, arteriovenous and arterioportal shunts
  • Superselective catheterization for transarterial treatment: Technical Pitfalls
  • Transradial approach for transarterial treatment
  • Transarterial treatment for large HCC
  • Dosimetry and treatment planning for radioembolization of HCC
Liver metastasis
  • Detecting early liver metastasis: The power of MRI with liver specific contrast
  • Percutaneous ablation in colorectal liver metastases
  • The role of chemoembolization for colorectal liver metastasis
  • The role of radioembolization for colorectal liver metastasis
Neuroendocrine tumor
  • The role of interventional oncology in the Management of Neuroendocrine tumor
Cholangiocarcinoma
  • The role of interventional oncology in the Management of Cholangiocarcinoma
Pancreatic cancer
  • The current status and role of medical oncology in advanced pancreatic cancer
  • Transarterial infusion for treatment of advanced pancreatic cancer
  • Advances and updates in the clinical application of irreversible electroporation (IRE) in pancreatic cancer
  • Combined chemotherapy and IRE in locally advanced pancreatic cancer
  • Clinical role and long-term outcomes of percutaneous IRE for pancreatic cancer
  • Technical considerations and pitfalls in IRE for pancreatic cancer
  • The advantage of open surgical approach for IRE of pancreatic cancer
Panel discussion and case presentations on IRE for pancreatic cancer: indications and contraindications, percutaneous approach or open surgical approach
Thyroid
  • Current guidelines on radiofrequency ablation of the thyroid
  • HIFU for benign thyroid lesions
  • Radiofrequency ablation of benign thyroid lesions
  • Technical advances of radiofrequency ablation for malignant thyroid lesions
  • Clinical outcome of radiofrequency ablation of malignant thyroid lesions
  • Thermal ablation for Grave’s disease: Technical considerations and outcomes
  • Ablation of parathyroid glands: Technical considerations and outcomes
  • Complications of thermal ablation for thyroid lesions
Renal cancer
  • Percutaneous microwave ablation for renal cancer: Technical considerations and outcomes
  • Percutaneous cryoablation for renal cancer: Technical considerations and outcomes
Brain tumor
  • Radioactive seeds for treatment of metastatic brain tumor and malignant glioma: Technical considerations and outcomes
Breast cancer
  • Thermal ablation for breast cancer: Technical considerations and outcomes
Case demonstrations of how I do it
Liver tumor:
  • US-guided RFA of HCC with Artificial Ascites: How I do it
  • Percutaneous microwave ablation of complex liver tumor
  • Superselective catheterization for transarterial treatment of HCC
Pancreatic tumor:
  • Percutaneous IRE for pancreatic cancer
  • Open surgical approach for IRE of locally advanced pancreatic cancer
Thyroid tumor:
  • RFA for malignant thyroid lesions
Brain tumor:
  • Radioactive seeds for treatment of metastatic brain tumor and malignant glioma
Renal tumor:
  • Percutaneous microwave ablation of complex renal tumor

There are no products to list in this category.